Simona Corso Selected Research

Simona Corso Research Topics

Disease

26	Neoplasms (Cancer) 04/2024 - 07/2004
13	Stomach Neoplasms (Stomach Cancer) 06/2023 - 05/2010
3	Adenocarcinoma 04/2024 - 08/2013
3	Neoplasm Metastasis (Metastasis) 12/2020 - 07/2004
3	Lung Neoplasms (Lung Cancer) 12/2017 - 12/2014
2	Amnesia (Dissociative Amnesia) 01/2023 - 01/2018
2	Melanoma (Melanoma, Malignant) 08/2020 - 12/2008
2	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 06/2013
2	Infections 04/2005 - 11/2003
1	Ataxia Telangiectasia (Louis Bar Syndrome) 04/2024
1	Inflammation (Inflammations) 03/2024
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Lymphoma (Lymphomas) 01/2018
1	Carcinoma (Carcinomatosis) 01/2018
1	Carcinogenesis 05/2006
1	Malaria 11/2003

Drug/Important Bio-Agent (IBA)

7	Phosphotransferases (Kinase)IBA 08/2020 - 01/2009
6	Trastuzumab (Herceptin)FDA Link 06/2023 - 01/2016
4	Proteins (Proteins, Gene)FDA Link 04/2024 - 12/2008
4	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2022 - 06/2005
3	Tyrosine Kinase InhibitorsIBA 01/2021 - 12/2017
3	tyrosine receptor (receptor, tyrosine)IBA 12/2018 - 01/2009
3	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 04/2005 - 11/2003
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2024 - 01/2023
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 08/2013
2	pertuzumabIBA 01/2023 - 01/2021
2	4-hexyloxyaniline (HOA)IBA 05/2022 - 03/2022
2	LigandsIBA 08/2020 - 07/2004
2	ErbB Receptors (EGF Receptor)IBA 12/2017 - 06/2013
2	Monoclonal AntibodiesIBA 12/2014 - 06/2013
2	IntegrinsIBA 12/2010 - 06/2005
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 04/2024
1	ChromatinIBA 03/2024
1	Interferon Type IIBA 03/2024
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 06/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023
1	olaparibIBA 01/2023
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2022
1	ChemokinesIBA 11/2022
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2022
1	Clofarabine (Clolar)FDA Link 01/2022
1	2- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidineIBA 01/2022
1	Lapatinib (GW572016)FDA Link 01/2021
1	Everolimus FDA Link 01/2021
1	SuspensionsIBA 12/2020
1	1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA 08/2020
1	Galectin 1 (LGALS1)IBA 08/2020
1	Neuropilin-1IBA 08/2020
1	Proto-Oncogene Proteins B-rafIBA 08/2020
1	Messenger RNA (mRNA)IBA 01/2019
1	Lactic Acid (Lactate)FDA LinkGeneric 12/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Rituximab (Mabthera)FDA Link 01/2018
1	RamucirumabIBA 01/2016
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2015
1	CrizotinibIBA 03/2015
1	TetraspaninsIBA 12/2010
1	Tyrosine (L-Tyrosine)FDA Link 05/2010
1	5- ((2,6- dichlorobenzyl)sulfonyl)- 3- ((3,5- dimethyl- 4- ((2- (pyrrolidin- 1- ylmethyl)pyrrolidin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- 1,3- dihydro- 2H- indol- 2- oneIBA 05/2010
1	MicroRNAs (MicroRNA)IBA 12/2008
1	AntagomirsIBA 12/2008
1	CD100 antigenIBA 07/2008
1	Small Interfering RNA (siRNA)IBA 05/2006
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 04/2005
1	plexinIBA 07/2004
1	Proto-Oncogene Proteins c-metIBA 11/2003

Therapy/Procedure

16	Therapeutics 04/2024 - 06/2005
2	Drug Therapy (Chemotherapy) 01/2023 - 08/2021
1	Aftercare (After-Treatment) 03/2022
1	Precision Medicine 11/2019